Similar Articles
1301 Is the American Association for the Study of Liver Diseases recommendation for hepatocellular carcinoma screening a cul-de-sac?
1302 High-intensity focused ultrasound ablation: An effective bridging therapy for hepatocellular carcinoma patients
1303 Overexpression of p42.3 promotes cell growth and tumorigenicity in hepatocellular carcinoma
1304 Mycotoxins are conventional and novel risk biomarkers for hepatocellular carcinoma
1305 Genetic association of interleukin-6 polymorphism (-174 G/C) with chronic liver diseases and hepatocellular carcinoma
1306 Hepatocellular carcinoma in patients with chronic kidney disease
1307 Trans-arterial chemo-embolization is safe and effective for very elderly patients with hepatocellular carcinoma
1308 Increased international normalized ratio level in hepatocellular carcinoma patients with diabetes mellitus
1309 Sorafenib and entecavir: The dioscuri of treatment for advanced hepatocellular carcinoma?
1310 Therapeutic efficacy of transarterial chemo-embolization with a fine-powder formulation of cisplatin for hepatocellular carcinoma
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA